FLSmidth A/S
31.3.2026 12:12:57 CEST | Globenewswire | Press release
FLSmidth closes the sale of its former corporate headquarters for a total net cash gain of DKK 730 million
FLSmidth closes the sale of its former corporate headquarters for a total net cash gain of DKK 730 million
PRESS RELEASE
FLSmidth & Co. A/S
31 March 2026
Copenhagen, Denmark
With reference to Company Announcement No. 9-2025, FLSmidth today announces that it has completed the share purchase agreement with Nrep and AG Gruppen (collectively, the “buying party”) for the disposal of all shares in FLSmidth’s subsidiary, Matr. No. 2055 A/S, which owns land and buildings located at Vigerslev Allé 77, Valby, Denmark.
The financial implications of the transaction are in line with the information disclosed in Company Announcement No. 9-2025, including net cash proceeds of approximately DKK 730 million and an accounting gain of approximately DKK 690 million, both of which will be recognised in the first quarter of 2026.
Contacts:
Media
Jannick Denholt, +45 21 69 66 57, jli@flsmidth.com
Investor Relations
Andreas Holkjær, +45 24 85 03 84, andh@flsmidth.com
Jannick Denholt, +45 21 69 66 57, jli@flsmidth.com
About FLSmidth
FLSmidth is a full flowsheet technology and service supplier to the global mining industry. We enable our customers to improve performance, lower operating costs and reduce environmental impact. MissionZero is our sustainability ambition towards zero emissions in mining by 2030. We work within fully validated Science-Based Targets, have a clear commitment to improving the sustainability performance of the global mining industry and aim to become carbon neutral in our own operations by 2030. www.fls.com
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S24.10.2026 13:00:00 CEST | Press release
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
ASYAD24.10.2026 12:47:36 CEST | Press release
Asyad Group to Host Muscat Maritime Resilience Forum to Strengthen Global Trade Networks
King Faisal Specialist Hospital & Research Centre24.10.2026 11:00:00 CEST | Press release
KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
Orion Oyj24.10.2026 08:35:00 CEST | Press release
Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence
Zymeworks Inc.24.10.2026 08:30:00 CEST | Press release
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom